Christina Rostrup Kruuse

Medicine & Life Sciences

1. Adenylyl Cyclases 15%
2. Arteries 15%
3. Atrial Fibrillation 20%
4. Calcitonin Gene-Related Peptide 33%
5. Cerebral Arteries 82%
6. Cerebrovascular Circulation 61%
7. Cerebrovascular Disorders 18%
8. Cilostazol 49%
9. Cross-Over Studies 16%
10. Cyclic AMP 22%
11. Cyclic GMP 32%
12. cyclic guanosine monophosphate-adenosine monophosphate 17%
13. Cyclic Nucleotides 15%
14. Dilatation 26%
15. Dipyridamole 24%
16. Duchenne Muscular Dystrophy 37%
17. Exercise 20%
18. Headache 91%
19. Healthy Volunteers 55%
20. Hemodynamics 25%
21. High-Intensity Interval Training 21%
22. Lacunar Stroke 32%
23. Magnetic Resonance Imaging 17%
24. Middle Cerebral Artery 49%
25. Migraine Disorders 100%
26. Migraine with Aura 21%
27. Migraine without Aura 39%
28. Nitric Oxide 21%
29. Nitric Oxide Donors 15%
30. Nitric Oxide Synthase Type I 30%
31. Nitroglycerin 34%
32. Phosphodiesterase 3 Inhibitors 25%
33. Phosphodiesterase 5 Inhibitors 49%
34. Phosphoric Diester Hydrolases 50%
35. Placebos 38%
36. Randomized Controlled Trials 20%
37. Regional Blood Flow 38%
38. Sildenafil Citrate 97%
39. Stroke 74%
40. Systematic Reviews 33%
41. Tadalafil 24%
42. Temporal Arteries 21%
43. Tomography 15%
44. Trigeminal Ganglion 33%
45. Type 5 Cyclic Nucleotide Phosphodiesterases 43%